IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ACHV

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents47.9628.0820.9331.9351.8713.0212.759.5414.7666.4015.5519.9225.0716.5124.7718.2029.3836.3443.0233.31
Short-term Investments139.351.1915.4816.183.5210.2321.6133.3746.56----------------------
Total Current Assets188.2931.0639.8950.0656.9025.0036.4745.5362.5267.7116.9821.9026.3818.2227.3320.9631.1537.6944.5934.73
Property, Plant & Equipment----0.00------0.01------0.01------0.00------0.020.02
Goodwill1.031.031.031.031.031.031.031.031.031.031.031.031.031.031.031.031.031.031.031.03
Intangible Assets0.640.700.750.810.860.920.971.031.091.141.201.251.311.361.421.481.531.591.641.70
Total Non-current Assets*2.152.041.901.992.032.362.172.392.272.322.392.442.542.572.642.772.842.922.923.07
Total Assets190.4433.1041.7952.0458.9427.3638.6347.9264.7970.0319.3724.3428.9220.8029.9723.7233.9940.6147.5237.80
Accounts Payable------1.941.221.661.951.010.550.370.620.640.361.061.660.410.660.420.840.82
Total Current Liabilities197.6611.839.089.738.577.136.686.7213.7020.5720.814.083.4520.3021.606.925.364.014.553.08
Total Non-current Liabilities*7.4610.5911.198.708.699.9511.059.828.800.000.0116.2215.770.050.0715.7615.4615.1714.920.02
Total Liabilities205.1222.4320.2718.4317.2717.0817.7316.5422.5120.5720.8220.3019.2220.3621.6722.6820.8219.1819.473.10
Retained Earnings(345.16)(270.39)(260.23)(245.56)(231.12)(218.40)(205.58)(193.22)(180.71)(172.24)(165.75)(160.27)(153.17)(144.93)(135.94)(124.70)(111.63)(101.16)(93.59)(86.43)
Total Stockholder Equity(14.68)10.6821.5233.6241.6710.2820.9031.3842.2949.46(1.45)4.049.700.448.301.0413.1721.4328.0434.70
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Research & Development------5.326.717.107.307.615.112.802.113.584.595.538.619.877.214.394.514.59
Selling, General & Admin------9.375.865.804.894.863.323.182.272.993.133.042.252.772.872.842.612.10
Interest Expense--------------0.370.800.810.790.780.710.570.550.480.400.36----
Net Income(74.77)(10.17)(14.66)(14.44)(12.72)(12.83)(12.36)(12.51)(8.46)(6.49)(5.48)(7.11)(8.24)(8.99)(11.23)(13.08)(10.47)(7.57)(7.15)(6.69)
Basic EPS(0.80)(0.19)(0.23)(0.28)(0.37)(0.37)(0.37)(0.36)(0.25)(0.26)(0.23)(0.34)(0.43)(0.50)(0.76)(1.35)(1.08)------
Diluted EPS(0.80)(0.19)(0.23)(0.28)(0.37)(0.37)(0.37)(0.36)(0.25)(0.26)(0.23)(0.34)(0.43)(0.50)(0.76)(1.35)(1.08)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(10.78)(6.93)(17.98)(11.33)(9.07)(11.09)(9.19)(10.37)(4.92)(5.29)(4.36)(5.14)(6.68)(8.30)(11.14)(11.31)(8.32)(6.78)(5.22)(8.69)
Capital Expenditures0.02------------------0.010.02----------------
Free Cash Flow*(10.79)------------------(4.37)(5.15)----------------
Investing Cash Flow(137.80)14.280.71(12.65)6.7011.3511.7213.27(46.57)--(0.01)(0.01)----------------
Financing Cash Flow168.460.026.264.0441.22--0.68(8.11)(0.15)56.110.000.0015.230.0517.710.131.360.1014.930.01
← Scroll for more columns →

* Derived from reported values